| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |